GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G&E Herbal Biotechnology Co Ltd (ROCO:4911) » Definitions » Cyclically Adjusted FCF per Share

G&E Herbal Biotechnology Co (ROCO:4911) Cyclically Adjusted FCF per Share : NT$-0.48 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is G&E Herbal Biotechnology Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

G&E Herbal Biotechnology Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was NT$0.152. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is NT$-0.48 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 15.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of G&E Herbal Biotechnology Co was 15.70% per year. The lowest was 1.90% per year. And the median was 8.80% per year.

As of today (2024-06-04), G&E Herbal Biotechnology Co's current stock price is NT$58.10. G&E Herbal Biotechnology Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was NT$-0.48. G&E Herbal Biotechnology Co's Cyclically Adjusted Price-to-FCF of today is .


G&E Herbal Biotechnology Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for G&E Herbal Biotechnology Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G&E Herbal Biotechnology Co Cyclically Adjusted FCF per Share Chart

G&E Herbal Biotechnology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.05 -1.05 -1.12 -0.99 -0.63

G&E Herbal Biotechnology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.98 -0.96 -1.00 -0.63 -0.48

Competitive Comparison of G&E Herbal Biotechnology Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, G&E Herbal Biotechnology Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G&E Herbal Biotechnology Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G&E Herbal Biotechnology Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where G&E Herbal Biotechnology Co's Cyclically Adjusted Price-to-FCF falls into.



G&E Herbal Biotechnology Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, G&E Herbal Biotechnology Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.152/131.7762*131.7762
=0.152

Current CPI (Mar. 2024) = 131.7762.

G&E Herbal Biotechnology Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.152 100.560 -0.199
201409 0.126 100.428 0.165
201412 -0.298 99.070 -0.396
201503 -0.655 99.621 -0.866
201506 -0.224 100.684 -0.293
201509 -1.134 100.392 -1.489
201512 -0.707 99.792 -0.934
201603 -1.172 100.470 -1.537
201606 0.123 101.688 0.159
201609 -0.602 101.861 -0.779
201612 -0.132 101.863 -0.171
201703 -0.085 102.862 -0.109
201706 -0.136 103.349 -0.173
201709 -0.255 104.136 -0.323
201712 -0.183 104.011 -0.232
201803 -0.147 105.290 -0.184
201806 -0.068 106.317 -0.084
201809 -0.111 106.507 -0.137
201812 -0.175 105.998 -0.218
201903 -0.192 107.251 -0.236
201906 -0.129 108.070 -0.157
201909 -0.076 108.329 -0.092
201912 -0.067 108.420 -0.081
202003 -0.079 108.902 -0.096
202006 -0.002 108.767 -0.002
202009 -0.016 109.815 -0.019
202012 -0.010 109.897 -0.012
202103 0.033 111.754 0.039
202106 -0.063 114.631 -0.072
202109 -0.104 115.734 -0.118
202112 -0.072 117.630 -0.081
202203 -0.031 121.301 -0.034
202206 0.041 125.017 0.043
202209 0.230 125.227 0.242
202212 1.493 125.222 1.571
202303 -0.228 127.348 -0.236
202306 0.056 128.729 0.057
202309 0.321 129.860 0.326
202312 1.788 129.419 1.821
202403 0.152 131.776 0.152

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


G&E Herbal Biotechnology Co  (ROCO:4911) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


G&E Herbal Biotechnology Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of G&E Herbal Biotechnology Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


G&E Herbal Biotechnology Co (ROCO:4911) Business Description

Traded in Other Exchanges
N/A
Address
No.92, Keji 5th Road, Annan District, Tainan City, TWN, 70995
G&E Herbal Biotechnology Co Ltd is a Taiwan based biopharmaceutical company. It is specialized in the production of western conventional drugs, Chinese traditional drugs, unclassified food, cosmetics, and health products. The company is focused on botanical extraction technology and products. Its products include botanical extract toner, total moisture conditioning cream, whitening clear cream and firming essence cream.

G&E Herbal Biotechnology Co (ROCO:4911) Headlines

No Headlines